Organogenesis Holdings Inc.
ORGO
$4.72
-$0.165-3.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 1,450.88% | 289.48% | -420.60% | 29.27% | -107.59% |
| Total Depreciation and Amortization | 5.63% | 16.72% | 21.49% | 1.25% | -58.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.86% | -14.24% | 287.38% | 49.56% | 518.38% |
| Change in Net Operating Assets | -155.62% | -558.09% | -14.25% | -75.04% | 76.49% |
| Cash from Operations | 3.04% | -48.04% | -45.20% | -100.16% | 36.08% |
| Capital Expenditure | -1.11% | 57.03% | 74.93% | 70.62% | 68.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.11% | 57.03% | 74.93% | 70.62% | 68.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,421.99% | -17.05% | -64.02% | -77.83% | 5.17% |
| Issuance of Common Stock | 106,200.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -58.82% | -275.84% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,993.58% | -16.62% | -63.85% | -111.00% | 5.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 647.78% | -52.25% | 1,116.13% | -8.05% | 216.53% |